|
|
 |
|
Viewing report
|
|
|
|
Epidemiology: Hepatitis C in China - Epidemic yet to reach its peak
Datamonitor, Nov 2011, Pages: 26
In 1999, an estimated 180 million people worldwide were infected with HCV, of whom 130 million were chronically infected and at risk of developing chronic liver disease, cirrhosis, and hepatocellular carcinoma. In China, more than 40 million people are estimated to be infected with HCV, thereby presenting a huge single market potential for anti-HCV drugs.
Features and benefits
- Gain insights into the estimates and forecast of prevalent HCV cases in China.
- Understand the genotype distribution of HCV in China.
- Gain insights into the possible underlying risk factors driving the epidemiology of HCV in China.
Highlights
- In 2010, there were 43.4 million men, women, and children infected with HCV in China. This is expected to increase to approximately 45.2 million cases by 2020.
- The number of prevalent HCV cases will continue to rise in China due to continued healthcare exposures and as the population of injection drug users, in which HCV is the most prevalent, continues to grow. The number of HCV cases in China will increase by approximately 4.3% from 2010 to 2020.
Your key questions answered
- What is the current HCV patient population in China?
- How will the HCV patient population change over the next decade in China?
- How do changes in the risk factors affect the trends in prevalent HCV cases in China?
|
|
|
|
